Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by USA Financial Formulas

USA Financial Formulas lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 47.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,348 shares of the medical equipment provider’s stock after selling 2,115 shares during the period. USA Financial Formulas’ holdings in Intuitive Surgical were worth $1,226,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter worth about $33,000. Mark Sheptoff Financial Planning LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $37,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $580.11 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $355.17 and a 12-month high of $584.60. The business has a 50 day simple moving average of $537.05 and a 200 day simple moving average of $496.50. The firm has a market capitalization of $206.62 billion, a price-to-earnings ratio of 93.27, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Citigroup upped their price target on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.